Harrow Health, Inc. ( HROW) - Key Metrics
HROW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.89 | -$0.46 | -$0.26 | -$0.26 |
| 2026Q1 | $1.19 | -$0.74 | -$0.24 | -$0.25 |
| 2025Q4 | $2.42 | $0.18 | $0.23 | $0.22 |
| 2025Q3 | $1.93 | $0.03 | $0.45 | $0.44 |
| 2025Q2 | $1.73 | $0.14 | -$0.02 | -$0.03 |
HROW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -23.08 |
| 2026Q1 | 0% | -11.91 |
| 2025Q4 | 0% | 68.06 |
| 2025Q3 | 0% | 438 |
| 2025Q2 | 0% | 54.54 |
HROW
Price: $28.75
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 114053
Market Capitalization: 1.1 billion